Ce-shi Chen
Principal Investigator
Cancer Biology
Kunming Institute of Zoology
China
Biography
Prof. Ce-Shi Chen, Principle Investigator, graduated from Nankai University in 1994, obtained his Ph.D from Chinese Academy of Sciences (CAS) in 1999, accepted his postdoctoral training at University of Virginia and Emory University from 1999 to 2005, was appointed as Tenure Track Assistant/Associate Professor at Albany Medical College from 2006-2010, and was recruited to Kunming Institute of Zoology, CAS in 2010. His research is mainly focused on the breast cancer targeted therapy, protein ubiquitination, gene transcription, breast cancer stem cells, and cancer animal models. He published more than 40 SCI papers in Cell Death Differ, Cancer Res, Oncogene, J Pathology, and Nat Genetics. His current H-index is 20. He has been invited to be reviewers for more than 10 funding agents and over 30 scientific journals.
Research Interest
Breast cancer targeted therapy,
Publications
-
Zhou Z, Liu R, Chen C. The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer. International journal of cancer. 2012 Apr 1;130(7):1504-10.
-
Kong Y, Chen J, Zhou Z, Xia H, Qiu MH, Chen C. Cucurbitacin E induces cell cycle G2/M phase arrest and apoptosis in triple negative breast cancer. PloS one. 2014 Jul 29;9(7):e103760.
-
Zhao D, Zhi X, Zhou Z, Chen C. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis. Carcinogenesis. 2011 Oct 31;33(1):59-67.
